They are planning on testing an inhalant version but who knows where that will land in terms of effectiveness. It might make things worse so that is much further out unless things are really lucky, which we haven’t had a lot of with coronavirus.
They are planning on testing an inhalant version but who knows where that will land in terms of effectiveness. It might make things worse so that is much further out unless things are really lucky, which we haven’t had a lot of with coronavirus.
https://www.thepharmaletter.com/article/ridgeback-bio-triall...
Here's the FAQ page for one of the biggest USA home IV companies. It's a good starting point if you're curious.
Basically you tell the FDA how to store and handle and the FDA says “ok, give me the data that proves the drug is stable under those conditions”.
Beyond that the FDA doesn’t really care who administers it.
Interestingly, their insurance company has been trying to push them into performing his infusions at home for a couple years, as it is more cost effective. My sister has to fight them on it every couple of months to continue having them performed at the hospital.
Genuinely curious.
Before the first infusion, she was advised by hospital staff that the insurance company might refuse coverage for infusions onsite if the procedure was ever performed in-home.
I myself have fear of needles, so I'm biased in this sense. I would not use this drug, except with a Oxazepam. Which I prefer not to, as these too are addictive.
An infusion is something that takes a longer time as the drug is taken slowly into the bloodstream (might be something that takes a couple of hours).
This doesn't seem wise; the side effects of remdesivir seem worse than the typical course of a cold/flu.